{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:12:26Z","timestamp":1791267146930,"version":"4.1.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry & Cell Biology"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.biocel.2009.04.012","type":"journal-article","created":{"date-parts":[[2009,4,22]],"date-time":"2009-04-22T04:27:46Z","timestamp":1240374466000},"page":"1855-1865","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":137,"title":["OPA1-associated disorders: Phenotypes and pathophysiology"],"prefix":"10.1016","volume":"41","author":[{"given":"Patrizia","family":"Amati-Bonneau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Milea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Bonneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Chevrollier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Ferr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Guillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na\u00efg","family":"Gueguen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Loiseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Anne Pou de","family":"Crescenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Verny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Procaccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Lenaers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Reynier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biocel.2009.04.012_bib1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/ng0501-92","article-title":"Gene therapy restores vision in a canine model of childhood blindness","volume":"28","author":"Acland","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.biocel.2009.04.012_bib2","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1167\/iovs.03-1093","article-title":"Developmental expression profile of the optic atrophy gene product: OPA1 is not localized exclusively in the mammalian retinal ganglion cell layer","volume":"45","author":"Aijaz","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.biocel.2009.04.012_bib3","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/brain\/awm005","article-title":"A splice site mutation in the murine OPA1 gene features pathology of autosomal dominant optic atrophy","volume":"130","author":"Alavi","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.biocel.2009.04.012_bib4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/79944","article-title":"OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28","volume":"26","author":"Alexander","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.biocel.2009.04.012_bib5","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/S0002-9394(03)00665-2","article-title":"The association of autosomal dominant optic atrophy and moderate deafness may be due to the R445H mutation in the OPA1 gene","volume":"136","author":"Amati-Bonneau","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.biocel.2009.04.012_bib6","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/ana.20681","article-title":"OPA1 R445H mutation in optic atrophy associated with sensorineural deafness","volume":"58","author":"Amati-Bonneau","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biocel.2009.04.012_bib7","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/brain\/awm298","article-title":"OPA1 mutations induce mitochondrial DNA instability and optic atrophy \u201cplus\u201d phenotypes","volume":"131","author":"Amati-Bonneau","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.biocel.2009.04.012_bib8","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1086\/514884","article-title":"A gene for X-linked optic atrophy is closely linked to the Xp11.4-Xp11.2 region of the X chromosome","volume":"61","author":"Assink","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.biocel.2009.04.012_bib9","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/sj.ejhg.5201070","article-title":"A first locus for isolated autosomal recessive optic atrophy (ROA1) maps to chromosome 8q","volume":"11","author":"Barbet","year":"2003","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.biocel.2009.04.012_bib10","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1136\/jmg.2004.025502","article-title":"A third locus for dominant optic atrophy on chromosome 22q","volume":"42","author":"Barbet","year":"2005","journal-title":"J Med Genet"},{"key":"10.1016\/j.biocel.2009.04.012_bib11","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/humu.9152","article-title":"Fourteen novel OPA1 mutations in autosomal dominant optic atrophy including two de novo mutations in sporadic optic atrophy","volume":"21","author":"Baris","year":"2003","journal-title":"Hum Mutat"},{"key":"10.1016\/j.biocel.2009.04.012_bib12","first-page":"125","article-title":"A family suffering from hereditary optic atrophy","volume":"16","author":"Batten","year":"1896","journal-title":"Trans Ophthalmol Soc UK"},{"key":"10.1016\/j.biocel.2009.04.012_bib13","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00401-004-0970-8","article-title":"OPA1, associated with autosomal dominant optic atrophy, is widely expressed in the human brain","volume":"109","author":"Bette","year":"2005","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.biocel.2009.04.012_bib14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.preteyeres.2003.10.003","article-title":"Mitochondrial dysfunction as a cause of optic neuropathies","volume":"23","author":"Carelli","year":"2004","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.biocel.2009.04.012_bib15","first-page":"A42","article-title":"Dominant optic atrophy (DAO) and sensorineural hearing loss: clinical, biochemical, spectroscopic and molecular genetic study of a large Italian pedigree linked to a new locus on chromosome 16","volume":"68","author":"Carelli","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.biocel.2009.04.012_bib16","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/ana.21385","article-title":"Hereditary optic neuropathies share a common mitochondrial coupling defect","volume":"63","author":"Chevrollier","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biocel.2009.04.012_bib17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cell.2006.06.021","article-title":"Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling","volume":"126","author":"Cipolat","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.biocel.2009.04.012_bib18","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ajo.2006.12.038","article-title":"Autosomal dominant optic atrophy: penetrance and expressivity in patients with OPA1 mutations","volume":"143","author":"Cohn","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.biocel.2009.04.012_bib19","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ana.21376","article-title":"Reversible optic neuropathy with OPA1 exon 5b mutation","volume":"63","author":"Cornille","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biocel.2009.04.012_bib20","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/hmg\/ddm079","article-title":"OPA1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function","volume":"16","author":"Davies","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.biocel.2009.04.012_bib21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/79936","article-title":"Nuclear gene OPA1, encoding a mitochondrial dynamin-related protien, is mutated in dominant optic atrophy","volume":"26","author":"Delettre","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.biocel.2009.04.012_bib22","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s00439-001-0633-y","article-title":"Mutation spectrum and splicing variants in the OPA1 gene","volume":"109","author":"Delettre","year":"2001","journal-title":"Hum Genet"},{"key":"10.1016\/j.biocel.2009.04.012_bib23","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/hmg\/3.6.977","article-title":"Dominant optic atrophy (OPA1) mapped to chromosome 3q region. I. Linkage analysis","volume":"3","author":"Eiberg","year":"1994","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.biocel.2009.04.012_bib24","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/humu.20161","article-title":"eOPA1: an online database for OPA1 mutations","volume":"25","author":"Ferr\u00e9","year":"2005","journal-title":"Hum Mutat"},{"key":"10.1016\/j.biocel.2009.04.012_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/humu.21025","article-title":"Molecular screening of 980 cases of suspected of hereditary optic neuropathy with a report on 77 novel OPA1 mutations","author":"Ferr\u00e9","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1016\/j.biocel.2009.04.012_bib26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cell.2006.06.025","article-title":"OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion","volume":"126","author":"Frezza","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.biocel.2009.04.012_bib27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/jmg.2008.062570","article-title":"Genomic rearrangements in OPA1 are frequent in patients with autosomal dominant optic atrophy","volume":"46","author":"Fuhrmann","year":"2009","journal-title":"J Med Genet"},{"key":"10.1016\/j.biocel.2009.04.012_bib28","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1101\/sqb.2007.72.024","article-title":"Sirtuins in aging and disease","volume":"72","author":"Guarente","year":"2007","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"10.1016\/j.biocel.2009.04.012_bib29","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/01.gim.0000214299.61930.c0","article-title":"OPA1 mutations and mitochondrial DNA haplotypes in autosomal dominant optic atrophy","volume":"8","author":"Han","year":"2006","journal-title":"Genet Med"},{"key":"10.1016\/j.biocel.2009.04.012_bib30","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/brain\/115.4.979","article-title":"Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation","volume":"115","author":"Harding","year":"1992","journal-title":"Brain"},{"key":"10.1016\/j.biocel.2009.04.012_bib31","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0161-6420(80)35247-0","article-title":"Autosomal dominant optic atrophy: a spectrum of disability","volume":"87","author":"Hoyt","year":"1980","journal-title":"Ophthalmology"},{"key":"10.1016\/j.biocel.2009.04.012_bib32","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/brain\/awm272","article-title":"Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance","volume":"131","author":"Hudson","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.biocel.2009.04.012_bib33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ymgme.2005.07.034","article-title":"Optic atrophies in metabolic disorders","volume":"86","author":"Huizing","year":"2005","journal-title":"Mol Genet Metab"},{"issue":"9","key":"10.1016\/j.biocel.2009.04.012_bib34","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1167\/iovs.07-0024","article-title":"Reduction of inner retinal thickness in patients with autosomal dominant optic atrophy associated with OPA1 mutations","volume":"48","author":"Ito","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.biocel.2009.04.012_bib35","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/0002-9394(79)90565-8","article-title":"A clinicopathologic study of autosomal dominant optic atrophy","volume":"88","author":"Johnston","year":"1979","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.biocel.2009.04.012_bib36","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1167\/iovs.03-1407","article-title":"Expression of the OPA1 mitochondrial protein in retinal ganglion cells: its downregulation causes aggregations of the mitochondrial network","volume":"46","author":"Kamei","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.biocel.2009.04.012_bib37","first-page":"481","article-title":"The G401D mutation of OPA1 causes autosomal dominant optic atrophy and hearing loss in a Chinese family","volume":"23","author":"Ke","year":"2006","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi"},{"key":"10.1016\/j.biocel.2009.04.012_bib38","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0002-9394(99)80236-0","article-title":"Clinical features of autosomal dominant congenital nystagmus linked to chromosome 6p12","volume":"125","author":"Kerrison","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.biocel.2009.04.012_bib39","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00439-004-1199-2","article-title":"Mitochondrial GTPase mitofusin 2 in Charcot-Marie-Tooth neuropathy type 2A","volume":"116","author":"Kijima","year":"2005","journal-title":"Hum Genet"},{"key":"10.1016\/j.biocel.2009.04.012_bib40","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1212\/01.WNL.0000157282.76715.B1","article-title":"Mitochondrial DNA content is decreased in autosomal optic atrophy","volume":"64","author":"Kim","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.biocel.2009.04.012_bib41","first-page":"1190","article-title":"Linkage analysis in dominant optic atrophy","volume":"35","author":"Kivling","year":"1983","journal-title":"Am J Hum Genet"},{"issue":"Suppl. 54","key":"10.1016\/j.biocel.2009.04.012_bib42","first-page":"1","article-title":"Infantile optic atrophy with dominant mode of inheritance: a clinical and genetic study of 19 Danish families","volume":"164","author":"Kjer","year":"1959","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.biocel.2009.04.012_bib43","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1755-3768.1983.tb01424.x","article-title":"Histopathology of eye, optic nerve and brain in a case of dominant optic atrophy","volume":"61","author":"Kjer","year":"1983","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"10.1016\/j.biocel.2009.04.012_bib44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-0420.1996.tb00672.x","article-title":"Dominant optic atrophy mapped to chromosome 3q region. II. Clinical and epidemiological aspects","volume":"74","author":"Kjer","year":"1996","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.biocel.2009.04.012_bib45","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1001\/archopht.1974.03900060105003","article-title":"Dominant congenital deafness and progressive optic nerve atrophy","volume":"91","author":"Konigsmark","year":"1974","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.biocel.2009.04.012_bib46","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1212\/01.wnl.0000168898.76071.70","article-title":"Clinical and electrophysiologic features of CMT2A with mutations in the mitofusin 2 gene","volume":"65","author":"Lawson","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.biocel.2009.04.012_bib47","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF01694557","article-title":"Ueber hereditaer und congenital angelegte Sehnervenleiden","volume":"17","author":"Leber","year":"1871","journal-title":"Graefes Arch Ophthalmol"},{"key":"10.1016\/j.biocel.2009.04.012_bib48","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/ajmg.a.30794","article-title":"Optic atrophy and sensorineural hearing loss in a family caused by an R445H OPA1 mutation","volume":"138A","author":"Li","year":"2005","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.biocel.2009.04.012_bib49","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00415-008-0571-x","article-title":"A phenotypic variation of dominant optic atrophy and deafness (ADOAD) due to a novel OPA1 mutation","volume":"255","author":"Liguori","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.biocel.2009.04.012_bib50","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/ana.20278","article-title":"Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy","volume":"56","author":"Lodi","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biocel.2009.04.012_bib51","first-page":"968","article-title":"Refinement of the OPA1 gene locus on chromosome 3q28-q29 to a region of 2-8 cM, in one Cuban pedigree with autosomal dominant optic atrophy type Kjer","volume":"57","author":"Lunkes","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.biocel.2009.04.012_bib52","series-title":"Genetic risk","author":"Lyle","year":"1990"},{"key":"10.1016\/j.biocel.2009.04.012_bib53","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1086\/346066","article-title":"The epidemiology of Leber hereditary optic neuropathy in the North East of England","volume":"72","author":"Man","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.biocel.2009.04.012_bib54","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1136\/jmg.39.8.e47","article-title":"Deletion of the OPA1 gene in a dominant optic atrophy family: evidence that haploinsufficiency is the cause of disease","volume":"39","author":"Marchbank","year":"2002","journal-title":"J Med Genet"},{"key":"10.1016\/j.biocel.2009.04.012_bib55","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2091-9-22","article-title":"Mitochondrial oxidative phosphorylation in autosomal dominant optic atrophy","volume":"9","author":"Mayorov","year":"2008","journal-title":"BMC Biochem"},{"key":"10.1016\/j.biocel.2009.04.012_bib56","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/13816818509007861","article-title":"Dominant optic nerve atrophy with progressive hearing loss and chronic progressive external ophthalmoplegia (CPEO)","volume":"5","author":"Meire","year":"1985","journal-title":"Ophthalmic Paediatr Genet"},{"key":"10.1016\/j.biocel.2009.04.012_bib57","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/13816818509007860","article-title":"Probable autosomal dominant optic atrophy with hearing loss","volume":"5","author":"Mets","year":"1985","journal-title":"Ophthalmic Paediatr Genet"},{"key":"10.1016\/j.biocel.2009.04.012_bib58","doi-asserted-by":"crossref","unstructured":"Milea D, Sander B, Wegener M, Jensen H, Kjer B, J\u00f8rgensen TM, Lund-Andersen H, Larsen M. Axonal loss occurs early in dominant optic atrophy. Acta Ophthalmol; 2009 [Epub ahead of print].","DOI":"10.1111\/j.1755-3768.2008.01469.x"},{"key":"10.1016\/j.biocel.2009.04.012_bib59","first-page":"598","article-title":"Acute and late-onset optic atrophy due to a novel OPA1 mutation leading to a mitochondrial coupling defect","volume":"15","author":"Nochez","year":"2009","journal-title":"Mol Vis"},{"key":"10.1016\/j.biocel.2009.04.012_bib60","doi-asserted-by":"crossref","first-page":"7743","DOI":"10.1074\/jbc.C200677200","article-title":"Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis","volume":"278","author":"Olichon","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biocel.2009.04.012_bib61","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/jcp.20950","article-title":"Effects of OPA1 mutations on mitochondrial morphology and apoptosis: relevance to ADOA pathogenesis","volume":"211","author":"Olichon","year":"2007","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.biocel.2009.04.012_bib62","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.ajo.2004.06.011","article-title":"Dominant optic atrophy, sensorineural hearing loss, ptosis, and ophthalmoplegia: a syndrome caused by a missense mutation in OPA1","volume":"138","author":"Payne","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.biocel.2009.04.012_bib63","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/hmg\/10.13.1359","article-title":"OPA1 mutations in patients with autosomal dominant optic atrophy and evidence for semi-dominant inheritance","volume":"10","author":"Pesch","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.biocel.2009.04.012_bib64","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1167\/iovs.03-1261","article-title":"OPA1, the disease gene for autosomal dominant optic atrophy, is specifically expressed in ganglion retinal cells and intrinsic neurons of the retina","volume":"45","author":"Pesch","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.biocel.2009.04.012_bib65","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1073\/pnas.0709336105","article-title":"The PINK1\/Parkin pathways regulates mitochondrial morphology","volume":"105","author":"Poole","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.biocel.2009.04.012_bib66","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1600-0420.2005.00448.x","article-title":"Dominant optic atrophy: correlation between clinical and molecular genetic studies","volume":"83","author":"Puomila","year":"2005","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.biocel.2009.04.012_bib67","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.ejhg.5201828","article-title":"Epidemiology and penetrance of Leber hereditary optic neuropathy in Finland","volume":"15","author":"Puomila","year":"2007","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.biocel.2009.04.012_bib68","doi-asserted-by":"crossref","first-page":"E110","DOI":"10.1136\/jmg.2003.016576","article-title":"OPA3 gene mutations responsible for autosomal dominant optic atrophy and cataract","volume":"41","author":"Reynier","year":"2004","journal-title":"J Med Genet"},{"issue":"Database issue","key":"10.1016\/j.biocel.2009.04.012_bib69","doi-asserted-by":"crossref","first-page":"D823","DOI":"10.1093\/nar\/gkl927","article-title":"An enhanced MITOMAP with a global mtDNA mutational phylogeny","volume":"35","author":"Ruiz-Pesini","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.biocel.2009.04.012_bib70","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/humu.20607","article-title":"Comprehensive cDNA study and quantitative transcript analysis of mutant OPA1 transcripts containing premature termination codons","volume":"29","author":"Schimpf","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1016\/j.biocel.2009.04.012_bib71","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0002-9394(02)01929-3","article-title":"A novel mutation in the OPA1 gene in a japanese patient with optic atrophy","volume":"135","author":"Shimizu","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.biocel.2009.04.012_bib72","first-page":"66","article-title":"Disease of the optic nerve. I. Hereditary or congenital optic atrophy and allied cases","volume":"17","author":"Snell","year":"1897","journal-title":"Trans Ophthalmol Soc UK"},{"key":"10.1016\/j.biocel.2009.04.012_bib73","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1093\/hmg\/ddn225","article-title":"A novel deletion in the GTPase domain of OPA1 causes defects in mitochondrial morphology and distribution, but not in function","volume":"17","author":"Spinazzi","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.biocel.2009.04.012_bib74","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1212\/01.wnl.0000335931.54095.0a","article-title":"OPA1 in multiple mitochondrial DNA deletion disorders","volume":"71","author":"Stewart","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.biocel.2009.04.012_bib75","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/s004390100600","article-title":"A frameshift mutation in exon 28 of the OPA1 gene explains the high prevalence of dominant optic atrophy in the Danish population: evidence for a founder effect","volume":"109","author":"Thiselton","year":"2001","journal-title":"Hum Genet"},{"key":"10.1016\/j.biocel.2009.04.012_bib76","first-page":"1715","article-title":"A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy","volume":"43","author":"Thiselton","year":"2002","journal-title":"Invest Ophthalmol Vis Res"},{"key":"10.1016\/j.biocel.2009.04.012_bib77","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1093\/hmg\/10.13.1369","article-title":"Spectrum, frequency and penetrance of OPA1 mutations in dominant optic atrophy","volume":"10","author":"Toomes","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.biocel.2009.04.012_bib78","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1212\/01.wnl.0000289194.89359.a1","article-title":"Multiple sclerosis-like disorder in OPA1-related autosomal dominant optic atrophy","volume":"70","author":"Verny","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.biocel.2009.04.012_bib79","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/jmg.35.10.793","article-title":"Clinical features, molecular genetics, and pathophysiology of dominant optic atrophy","volume":"35","author":"Votruba","year":"1998","journal-title":"J Med Genet"},{"key":"10.1016\/j.biocel.2009.04.012_bib80","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1126\/science.3201231","article-title":"Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy","volume":"242","author":"Wallace","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.biocel.2009.04.012_bib81","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0804871105","article-title":"Amyloid beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission\/fusion proteins","author":"Wang","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.biocel.2009.04.012_bib82","article-title":"Effects of overexpression of Huntingtin proteins on mitochondrial integrity","author":"Wang","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.biocel.2009.04.012_bib83","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1056\/NEJMoa064436","article-title":"A lethal defect of mitochondrial and peroxisomal fission","volume":"356","author":"Waterham","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.biocel.2009.04.012_bib84","doi-asserted-by":"crossref","first-page":"7070","DOI":"10.1073\/pnas.0711845105","article-title":"Pink1 regulates mitochondrial dynamics through interaction with the fission\/fusion machinery","volume":"105","author":"Yang","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.biocel.2009.04.012_bib85","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1371\/journal.pgen.0040006","article-title":"The molecular mechanisms of OPA1-mediated optic atrophy in Drosophila model and prospects for antioxidant treatment","volume":"4","author":"Yarosh","year":"2008","journal-title":"PLoS Genet"},{"key":"10.1016\/j.biocel.2009.04.012_bib86","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/brain\/awm335","article-title":"OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion","volume":"131","author":"Zanna","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.biocel.2009.04.012_bib87","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/brain\/awm339","article-title":"OPA1 mutations and mitochondrial DNA damage: keeping the magic circle in shape","volume":"131","author":"Zeviani","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.biocel.2009.04.012_bib88","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/ng1341","article-title":"Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A","volume":"36","author":"Z\u00fcchner","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.biocel.2009.04.012_bib89","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.20797","article-title":"Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2","volume":"59","author":"Z\u00fcchner","year":"2006","journal-title":"Ann Neurol"}],"container-title":["The International Journal of Biochemistry & Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272509001320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272509001320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T06:42:06Z","timestamp":1761201726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272509001320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":89,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S1357272509001320"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2009.04.012","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"OPA1-associated disorders: Phenotypes and pathophysiology","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2009.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}